Resistance to antituberculosis drugs in Japan

Tubercle and Lung Disease

Volumn 77, Issue 2, 1996, Pages 130-135

  Hirano, K ^a   Kazumi, Y ^a   Abe, C ^a,b   Mori, T ^a   Aoki, M ^a   Aoyagi, T ^a  

^a Tuberculosis Research Committee   (Japan)

^b RESEARCH INSTITUTE OF TUBERCULOSIS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; KANAMYCIN; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; AGE; AGED; ARTICLE; BACTERIUM CULTURE; DRUG SENSITIVITY; FEMALE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; RECURRENT DISEASE; RISK FACTOR; TUBERCULOSIS;

EID: 0029970385     PISSN: 09628479     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0962-8479(96)90027-1     Document Type: Article

References (17)

1. Barnes P F, Bloch A B, Davidson P T, Snider D E Jr. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1991; 324: 1644-1650.
2. Rieder H L, Cauthen G M, Comstock G W, Snider D E Jr. Epidemiology of tuberculosis in the United States. Epidemiol Rev 1989; 11: 79-98.
3. CDC. Tuberculosis among foreign-born persons entering the United States: recommendations of the Advisory Committee for Elimination of Tuberculosis. MMWR 1990; 39: 1-5.
4. Brudney K, Dobkin J. Resurgent tuberculosis in New York City: human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis 1991; 144: 745-749.
5. CDC. Nosocomial transmission of multidrug-resistant tuberculosis to health care workers and HIV-infected patients in an urban hospital - Florida. MMWR 1990; 39: 718-722.
6. CDC. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons - Florida and New York, 1988-1991. MMWR 1991; 40: 585-591.
7. Edlin B R, Tokars J I, Grieco M H et al. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med 1992; 326: 1514-1521.
8. Pearson M L, Jereb J A, Frieden T R et al. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis: a risk to patients and health care workers. Ann Intern Med 1992; 117: 191-196.
9. CDC. Transmission of multidrug-resistant tuberculosis among immuno-compromised persons in a correctional system - New York, 1991. MMWR 1992; 41: 507-509.
10. Gangadharam P R J. Drug resistance in mycobacteria. Florida: CRC Press, 1984: p 7.
11. Ryohken. Primary drug resistance to the major anti-tuberculosis drugs in Japan. Tubercle 1970; 51: 152-171.
12. Ryohken. A study on prevalence of resistance to major drugs among newly admitted pulmonary tuberculosis patients in 1972: comparison of results in 1972 with those in 1957, 1959, 1961, 1963, 1966, and 1969. Kekkaku 1975; 50: 1-8.
13. Ryohken. A study on prevalence of resistance to primary and secondary drugs among newly admitted pulmonary tuberculosis patients in 1977: comparison of results in 1977 with those in 1957, 1959, 1961, 1963, 1966, 1969. and 1972. Kekkaku 1979; 54: 515-522.
14. Ryoken. A study of drug resistance of newly admitted pulmonary tuberculosis patients: prevalence of drug resistance according to the sensitivity test at local laboratories, and its trend over twenty-five years in Japan. Kekkaku 1991; 66: 367-373.
15. Japanese Society for Tuberculosis. Chemotherapy of Tuberculosis. Kekkaku 1974; 49: 349-356.
16. Bloch A B, Cauthen G M, Onorato I M et al. Nationwide survey of drug-resistant tuberculosis in the United States. JAMA 1994; 271: 665-671.
17. Kim S J, Hong Y P. Drug resistance of Mycobacterium tuberculosis in Korea. Tubercle Lung Dis 1992; 73: 219-224.